Cecilia Arfvidsson

523 total citations
23 papers, 384 citations indexed

About

Cecilia Arfvidsson is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cecilia Arfvidsson has authored 23 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cecilia Arfvidsson's work include Biosimilars and Bioanalytical Methods (8 papers), Ethics in Clinical Research (4 papers) and thermodynamics and calorimetric analyses (3 papers). Cecilia Arfvidsson is often cited by papers focused on Biosimilars and Bioanalytical Methods (8 papers), Ethics in Clinical Research (4 papers) and thermodynamics and calorimetric analyses (3 papers). Cecilia Arfvidsson collaborates with scholars based in Sweden, United Kingdom and United States. Cecilia Arfvidsson's co-authors include Karl‐Gustav Wahlund, Li‐Ming Gan, Rainard Fuhr, Regina Fritsche‐Danielson, Thomas Koernicke, Kenneth R. Chien, James D. Thompson, Michael Kjær, Anna Rudvik and Maria Lagerström‐Fermér and has published in prestigious journals such as Circulation, Nature Communications and Analytical Biochemistry.

In The Last Decade

Cecilia Arfvidsson

21 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilia Arfvidsson Sweden 11 181 88 55 41 36 23 384
Antonı́n Vacek Czechia 12 83 0.5× 65 0.7× 59 1.1× 31 0.8× 15 0.4× 28 346
Cavan Kalonia United States 12 534 3.0× 13 0.1× 48 0.9× 12 0.3× 193 5.4× 23 604
Daniel Weinbuch Netherlands 8 266 1.5× 12 0.1× 57 1.0× 4 0.1× 150 4.2× 8 348
Michael Z. Wang United States 14 338 1.9× 17 0.2× 61 1.1× 8 0.2× 30 0.8× 21 667
Victor Vai Tak Wong Singapore 12 194 1.1× 5 0.1× 16 0.3× 9 0.2× 109 3.0× 15 380
Inn H. Yuk United States 16 788 4.4× 5 0.1× 49 0.9× 38 0.9× 132 3.7× 30 875
Jin Yan United States 6 69 0.4× 20 0.2× 158 2.9× 3 0.1× 35 1.0× 8 321
Kejie Chen China 9 200 1.1× 9 0.1× 22 0.4× 12 0.3× 162 4.5× 22 407
Philip Lester Germany 12 294 1.6× 8 0.1× 35 0.6× 4 0.1× 73 2.0× 13 469
Stefan K. Maier Germany 6 295 1.6× 16 0.2× 16 0.3× 2 0.0× 22 0.6× 8 488

Countries citing papers authored by Cecilia Arfvidsson

Since Specialization
Citations

This map shows the geographic impact of Cecilia Arfvidsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Arfvidsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Arfvidsson more than expected).

Fields of papers citing papers by Cecilia Arfvidsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Arfvidsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Arfvidsson. The network helps show where Cecilia Arfvidsson may publish in the future.

Co-authorship network of co-authors of Cecilia Arfvidsson

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Arfvidsson. A scholar is included among the top collaborators of Cecilia Arfvidsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Arfvidsson. Cecilia Arfvidsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Henry, Scott P., Cecilia Arfvidsson, David Crowe, et al.. (2022). Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs. Nucleic Acid Therapeutics. 32(5). 369–377. 8 indexed citations
4.
Arfvidsson, Cecilia, et al.. (2021). A validated surrogate analyte LC-MS/MS assay for quantification of endogenous cortisol in human whole blood. Journal of Pharmaceutical and Biomedical Analysis. 198. 114028–114028. 11 indexed citations
5.
Ledvina, Aaron R., et al.. (2021). High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study. Bioanalysis. 13(17). 1343–1353. 6 indexed citations
6.
Nilsson, Catarina, Brett P. Monia, Dinko Rekić, et al.. (2020). Abstract 13913: Single Dose Safety, Pharmacokinetics, and Pharmacodynamics of a Potent PCSK9 Synthesis Inhibitor, AZD8233, in Subjects With Elevated Ldl Cholesterol. Circulation. 142(Suppl_3). 1 indexed citations
7.
Bailey, Christopher J., et al.. (2020). Giving Patients Choices: AstraZeneca’s Evolving Approach to Patient-Centric Sampling. Bioanalysis. 12(13). 957–970. 10 indexed citations
8.
Xu, Hongmei, Ganesh Mugundu, Martin Scott, et al.. (2019). Population pharmacokinetic analysis of danvatirsen supporting flat dosing switch. Journal of Pharmacokinetics and Pharmacodynamics. 46(1). 65–74. 11 indexed citations
9.
Hamrén, Ulrika Wählby, et al.. (2019). <p>Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers</p>. Drug Design Development and Therapy. Volume 13. 3845–3853. 7 indexed citations
10.
Gan, Li‐Ming, Maria Lagerström‐Fermér, Leif Carlsson, et al.. (2019). Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes. Nature Communications. 10(1). 871–871. 152 indexed citations
11.
Arfvidsson, Cecilia, et al.. (2019). Data Integrity in Regulated Bioanalysis: A Summary from the European Bioanalysis Forum Workshop in Collaboration with the MHRA. Bioanalysis. 11(13). 1227–1231. 2 indexed citations
12.
Cullberg, Marie, Cecilia Arfvidsson, Bengt Larsson, et al.. (2018). Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers. Drugs in R&D. 18(2). 149–159. 19 indexed citations
13.
Cheung, S. Y. Amy, Joanna Parkinson, Corina Dota, et al.. (2018). A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation. Journal of Pharmacokinetics and Pharmacodynamics. 45(3). 365–381. 5 indexed citations
14.
Arfvidsson, Cecilia, et al.. (2017). Astrazeneca and Covance Laboratories Clinical Bioanalysis Alliance: an Evolutionary Outsourcing Model. Bioanalysis. 9(15). 1181–1194. 5 indexed citations
15.
Arfvidsson, Cecilia & Karl‐Gustav Wahlund. (2003). Mass overloading in the flow field-flow fractionation channel studied by the behaviour of the ultra-large wheat protein glutenin. Journal of Chromatography A. 1011(1-2). 99–109. 33 indexed citations
16.
Arfvidsson, Cecilia, Karl‐Gustav Wahlund, & A.‐C. Eliasson. (2003). Direct molecular weight determination in the evaluation of dissolution methods for unreduced glutenin. Journal of Cereal Science. 39(1). 1–8. 20 indexed citations
17.
Arfvidsson, Cecilia & Karl‐Gustav Wahlund. (2003). Time-minimized determination of ribosome and tRNA levels in bacterial cells using flow field–flow fractionation. Analytical Biochemistry. 313(1). 76–85. 33 indexed citations
18.
Arfvidsson, Cecilia, et al.. (2003). Enhanced ribosome and tRNA contents in Escherichia coli expressing a truncated Vitreoscilla hemoglobin mutant analyzed by flow field-flow fractionation. Biotechnology Letters. 25(18). 1499–1504. 16 indexed citations
19.
Roos, Viktoria, et al.. (2002). Expression of Double Vitreoscilla Hemoglobin Enhances Growth and Alters Ribosome and tRNA Levels in Escherichia coli. Biotechnology Progress. 18(3). 652–656. 16 indexed citations
20.
Wittgren, Bengt, Karl‐Gustav Wahlund, Mats Andersson, & Cecilia Arfvidsson. (2002). Polysaccharide Characterization by Flow Field-Flow Fractionation-Multiangle Light Scattering: Initial Studies of Modified Starches. International Journal of Polymer Analysis and Characterization. 7(1-2). 19–40. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026